Past Journal Clubs |
Date
(Presenter) |
Article |
July 23, 2019
(Gerak)
|
Operant Social Reward Decreases Incubation of
Heroin Craving in Male and Female Rats |
July 9, 2019
|
Does cannabis legalisation change
healthcare utilisation? A population based
study using the healthcare cost
and utilisation project in Colorado, USA |
June 25, 2019
|
- Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
- Association between medical cannabis laws and opioid overdose mortality has reversed over time
|
June 11, 2019
|
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial. |
May 28, 2019
|
Can CBD Really Do All That? |
May 14, 2019
(Alex Wasserman, PhD)
|
Combined cognitive and parent training interventions for adolescents with ADHD and their mothers: A randomized control trial |
23 April
(Donald Dougherty, PhD) |
Reciprocal Relationships Between Parenting Behavior
and Disruptive Psychopathology from Childhood
Through Adolescence
Please note room change - This will be held in the Cellular and Integrative Physiology large conference room (3.078V) |
12 March
(TJ Moon)
|
The Role of Behavioral Phenotypes on Impaired Driving
Recidivism Risk and Treatment Response to Brief
Intervention: A Preliminary Study |
26 March
(Charles Mathias, PhD) |
Mandating Treatment Based on Interlock Performance:
Evidence for Effectiveness |
9 April
|
No Addiction Journal Club |
12 February
(Kelly McGlothen-Bell,
Lisa Cleveland)
|
- Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving Treatment
- News Brief: US Legislators Take a Scattered Approach to Neonatal Abstinence Syndrome
|
26 February
(Kelly McGlothen-Bell, Lisa Cleveland)
|
-
Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome A Randomized Clinical Trial
- An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome
|
|
22 January
(Jennifer Potter)
|
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial |
08 January
(Kristen Rosen)
|
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment |
27 November
(Lynette Daws
&
Lee Gilman) |
Corticosterone Potentiation of Cocaine-Induced Reinstatement of Conditioned Place Preference in Mice is Mediated by Blockade of the Organic Cation Transporter 3 |
13 November
(Lynette Daws
&
Lee Gilman) |
Corticosterone Acts in the Nucleus Accumbens to Enhance Dopamine Signaling and Potentiate Reinstatement of Cocaine Seeking |
23 October
|
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016
|
9 October
(Lisa Gerak) |
A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates |
25 September
(Vanessa Minervini) |
- Loperamide misuse and abuse
- Isopropyl Alcohol Swabs as a Preferred Substance of Abuse
|
11 September
|
A molecular mechanism for choosing alcohol over an alternative reward |
Cannabidiol Series |
Date
(Presenter) |
Article |
10 July
(Sabrina Blackledge) |
Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis. |
26 June
(Brett Ginsburg) |
Cannabidiol attenuates the appetitive effects of Δ 9-tetrahydrocannabinol in humans smoking their chosen cannabis |
12 June
| No Journal Club due to CPDD |
22 May
(Brenda Gannon) |
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol |
8 May
(David Maguire)
|
Cannabidiol potentiates Δ 9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. |
24 April
| No Journal Club due to EB |
10 April
(Lisa Gerak) |
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro |
Targeted deep brain stimulation for the treatment of addiction |
| Date |
Article |
| 6 February |
Spotlight on pain: optogenetic approaches for interrogating somatosensory circuits |
| 20 February |
Refining deep brain stimulation to
emulate optogenetic treatment of
synaptic pathology |
| 6 March |
Rehabilitating the addicted
brain with transcranial
magnetic stimulation |
| 20 March |
High frequency repetitive transcranial magnetic stimulation of the left
dorsolateral prefrontal cortex for methamphetamine use disorders: A
randomised clinical trial |
Kratom Series |
| Date |
Article |
| 7 November |
Review: Neurobiology of Kratom and its main alkaloid mitragynine |
| 28 November |
Antinociceptive effect of 7-hydroxymitragynine in mice:
Discovery of an orally active opioid analgesic from the
Thai medicinal herb Mitragyna speciosa |
| 12 December |
Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program |
| 9 January |
Withdrawal of Notice of Intent to Temporarily Place Mitragynine and 7-Hydroxymitragynine Into Schedule I
DEA Announces Intent to Schedule Kratom
Kratom Drug Ban May Cripple Promising Painkiller Research
Kratom: The Bitter Plant that Could Help Opioid Addicts—if the DEA doesn't ban it |
| Related Articles to this topic: |
What happens if kratom becomes illegal? |
